3a. Ascites Flashcards

1
Q

increased hepatic resistance in cirrhosis

A
  • First, the development of hepatic fibrosis, which defines cirrhosis, disrupts the normal architecture of the hepatic sinusoids and impedes normal blood flow through the liver.
  • Second, activation of hepatic stellate cells, which mediate fibrogenesis, leads to smooth-muscle contraction and fibrosis.
  • Finally, cirrhosis is associated with a decrease in endothelial nitric oxide synthetase (eNOS) production, which results in decreased nitric oxide production and increased intrahepatic vasoconstriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

increased hepatic resistance causes

A

portal hypertesnion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

portal hypertension and renal salt and water retention causes

A

ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ascites in patients with cirrhosis is caused by

A

portal hypertension and renal salt and water retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why does renal water and salt retention occur in liver cirrhosis

A
  1. increased systemic levels of nitric oxide (in contrast to the decrease seen intrahepatically), and increased levels of vascular endothelial growth factor and tumor necrosis factor, that result in splanchnic arterial vasodilation.
  2. Vasodilation of the splanchnic circulation results in pooling of blood and a decrease in the effective circulating volume, which is perceived by the kidneys as hypovolaemia.
  3. Compensatory vasoconstriction via release of antidiuretic hormone ensues, causing free water retention and activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system, which lead to renal sodium and water retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pathogenesis of ascites in the absence of cirrhosis

A

generally results from peritoneal carcinomatosis, peritoneal infection, or pancreatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

peritoneal carcinomatosis can result from

A

can result from primary peritoneal malignancies such as mesothelioma or sarcoma, abdominal malignancies such as gastric or colonic adenocarcinoma, or metastatic disease from breast or lung carcinoma or melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

peritoneal carcinomatosis causes ascites by

A

The tumor cells lining the peritoneum produce a protein-rich fluid that contributes to the development of ascites. Fluid from the extracellular space is drawn into the peritoneum, further contributing to the development of ascites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pancreatic ascites results from

A

leakage of pancreatic enzymes into the peritoneum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

total causes of ascites

A
  1. mainly cirrhosis
  2. some others: Cardiac ascites, peritoneal carcinomatosis, and “mixed” ascites resulting from cirrhosis and a second disease
  3. Less common: massive hepatic metastasis, infection (tuberculosis, Chlamydia infection), pancreatitis, and renal disease (nephrotic syndrome).
  4. Rare causes of ascites include hypothyroidism and familial Mediterranean fever.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

aetiology of ascites is best determined by

A

paracentesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

paracenesis is

A

procedure in which a needle or small catheter is passed transcutaneously to extract ascitic fluid from the peritoneum. The lower quadrants are the most frequent sites for paracentesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

preferred location for paracentesis

A

The left lower quadrant is preferred because of the greater depth of ascites and the thinner abdominal wall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

risks of paracentesis

A

Paracentesis is a safe procedure even in patients with coagulopathy; complications, including abdominal wall hematomas, hypotension, hepatorenal syndrome, and infection, are infrequent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

turbid fluid

A

result from the presence of infection or tumor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

white, milky fluid

A

indicates a triglyceride level >200 mg/dL (and often >1000 mg/dL), which is the hallmark of chylous ascites.

17
Q

chylous ascites

A

Chylous ascites results from lymphatic disruption that may occur with trauma, cirrhosis, tumor, tuberculosis, or certain congenital abnormalities.

18
Q

dark brown fluid

A

can reflect a high bilirubin concentration and indicates biliary tract perforation.

19
Q

black fluid

A

may indicate the presence of pancreatic necrosis or metastatic melanoma.

20
Q

testing ascitic fluid

A

should be sent for measurement of albumin and total protein levels, cell and differential counts, and, if infection is suspected, Gram’s stain and culture

21
Q

SAAG stands for

A

serum-ascites albumin gradient

22
Q

SAAG is useful for

A

distinguishing ascites caused by portal hypertension from nonportal hypertensive ascites

23
Q

SAAG reflects

A

the pressure within the hepatic sinusoids and correlates with the hepatic venous pressure gradient

24
Q

A SAAG ≥1.1 g/dL reflects

A

the presence of portal hypertension and indicates that the ascites is due to increased pressure in the hepatic sinusoids.
Possible causes include cirrhosis, cardiac ascites, hepatic vein thrombosis (Budd-Chiari syndrome), sinusoidal obstruction syndrome (veno-occlusive disease), or massive liver metastases

25
Q

A SAAG <1.1 g/dL indicates

A

ascites is not related to portal hypertension, as in tuberculous peritonitis, peritoneal carcinomatosis, or pancreatic ascites.

26
Q

treatment for cirrhotic ascites

A

is restriction of sodium intake to 2 g/d. When sodium restriction alone is inadequate to control ascites, oral diuretics—typically the combination of spironolactone and furosemide—are used to increase urinary sodium excretion

27
Q

Fluid intake may be restricted in patients with

A

hyponatraemia

28
Q

spironolactone

A

aldosterone antagonist that inhibits sodium resorption in the distal convoluted tubule of the kidney. Use of spironolactone may be limited by hyponatremia, hyperkalemia, and painful gynecomastia

29
Q

furosemide

A

is a loop diuretic that is generally combined with spironolactone in a ratio of 40:100; maximal daily doses of spironolactone and furosemide are 400 mg and 160 mg, respectively.

30
Q

common complication of cirrhotic ascites

A

Spontaneous bacterial peritonitis

31
Q

Spontaneous bacterial peritonitis presents as

A

Patients with SBP generally note an increase in abdominal girth; however, abdominal tenderness is found in only 40% of patients, and rebound tenderness is uncommon.
Patients may present with fever, nausea, vomiting, or the new onset or an exacerbation of preexisting hepatic encephalopathy.